• This record comes from PubMed

Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study

. 2020 Jul 15 ; 19 (1) : 170. [epub] 20200715

Language English Country Great Britain, England Media electronic

Document type Journal Article

Grant support
CZ.1.05/1.1.00/02.0123 European Regional Development Fund
316345 7th Framework Program of the European Union
NT13434-4/2012 Ministerstvo Zdravotnictví Ceské Republiky
R01 AG057708 NIA NIH HHS - United States
LQ1605 National Program of Sustainability II (MEYS CR)

Links

PubMed 32669093
PubMed Central PMC7362636
DOI 10.1186/s12944-020-01345-0
PII: 10.1186/s12944-020-01345-0
Knihovny.cz E-resources

BACKGROUND: The term arterial stiffness (ArSt) describes structural changes in arterial wall related to the loss of elasticity and is known as an independent predictor of cardiovascular diseases (CVD). The evidence relating to ArSt and triglycerides (TG) shows contradictory results. This paper means to survey the association between high TG and ArSt, utilizing the cardio-ankle vascular index (CAVI). METHODS: Subjects aged between 25 and 64 years from a random population-based sample were evaluated between 2013 and 2016. Data from questionnaires, blood pressure, anthropometric measures, and blood samples were collected and analyzed. CAVI was measured using VaSera VS-1500 N devise. Subjects with a history of CVD or chronic renal disease were excluded. RESULTS: One thousand nine hundred thirty-four participants, 44.7% of males, were included. The median age was 48 (Interquartile Range [IQR] 19) years, TG levels were 1.05 (0.793) mmol/L, and CAVI 7.24 (1.43) points. Prevalence of high CAVI was 10.0% (14.5% in males and 6.4% in females; P < 0.001) and prevalence of hypertriglyceridemia was 20.2% (29.2% in males and 13% in females, P < 0.001). The correlation between TG and CAVI was 0.136 (P < 0.001). High CAVI values were more prevalent among participants with metabolic syndrome (MetS), high blood pressure, dysglycemia, abdominal obesity, high LDL-cholesterol (LDL-c), and high total cholesterol. Using binary regression analysis, high TG were associated with high CAVI, even after adjustment for other MetS components, age, gender, smoking status, LDL-c, and statin treatment (β = 0.474, OR = 1.607, 95% CI = 1.063-2.429, P = 0.024). CONCLUSION: TG levels were correlated with ArSt, measured as CAVI. High TG was associated with high CAVI independent of multiple cardiometabolic risk factors. Awareness of the risks and targeted treatment of hypertriglyceridemia could further benefit in reducing the prevalence of CVD and events.

See more in PubMed

Institute for Health Metrics and Evaluation (IHME). GBD Compare. Seattle, WA:IHME, University of Washington [ http://vizhub.healthdata.org/gbd-compare].

Bonarjee VVS. Arterial stiffness: a prognostic marker in coronary heart disease. Available Methods and Clinical Application. Front Cardiovasc Med. 2018;5:64. doi: 10.3389/fcvm.2018.00064. PubMed DOI PMC

Sato Y, Nagayama D, Ban N, Kawana H, Nagumo A, Ohira M, Endo K, Saiki A, Shirai K, Tatsuno I. Cardio ankle vascular index (CAVI) is an independent predictor of cardiovascular events. Eur Heart J. 2013;34:P1586. doi: 10.1093/eurheartj/eht308.P1586. DOI

Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011;18:924–938. doi: 10.5551/jat.7716. PubMed DOI

Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord. 2011;11:51. doi: 10.1186/1471-2261-11-51. PubMed DOI PMC

Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Heart J Suppl. 2017;19:B4–B10. doi: 10.1093/eurheartj/suw058. DOI

Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Hiratsuka A, Matsuzaki M. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res. 2008;31:1347–1355. doi: 10.1291/hypres.31.1347. PubMed DOI

Wen J, Huang Y, Lu Y, Yuan H. Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population. Hypertens Res. 2019;42:1223–1230. doi: 10.1038/s41440-019-0251-5. PubMed DOI PMC

Zhan B, Huang X, Wang J, Qin X, Zhang J, Cao J, Song Y, Liu L, Li P, Yang R, et al. Association between lipid profiles and arterial stiffness in Chinese patients with hypertension: insights from the CSPPT. Angiology. 2019;70:515–522. doi: 10.1177/0003319718823341. PubMed DOI

Kubozono T, Miyata M, Ueyama K, Nagaki A, Otsuji Y, Kusano K, Kubozono O, Tei C. Clinical significance and reproducibility of new arterial distensibility index. Circ J. 2007;71:89–94. doi: 10.1253/circj.71.89. PubMed DOI

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120:1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. PubMed DOI

Nam SH, Kang SG, Lee YA, Song SW, Rho JS. Association of Metabolic Syndrome with the Cardioankle vascular index in asymptomatic Korean population. J Diabetes Res. 2015;2015:328585. doi: 10.1155/2015/328585. PubMed DOI PMC

Yue M, Liu H, He M, Wu F, Li X, Pang Y, Yang X, Zhou G, Ma J, Liu M, et al. Gender-specific association of metabolic syndrome and its components with arterial stiffness in the general Chinese population. PLoS One. 2017;12:e0186863. doi: 10.1371/journal.pone.0186863. PubMed DOI PMC

Liu H, Zhang X, Feng X, Li J, Hu M, Yambe T. Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese. Metab Syndr Relat Disord. 2011;9:105–110. doi: 10.1089/met.2010.0019. PubMed DOI

Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Fernando R, Marti R, Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez JA, Ramos R, et al. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016;15:148. doi: 10.1186/s12933-016-0465-7. PubMed DOI PMC

Elosua-Bayes M, Marti-Lluch R, Garcia-Gil MDM, Camos L, Comas-Cufi M, Blanch J, Ponjoan A, Alves-Cabratosa L, Elosua R, Grau M, et al. Association of Classic Cardiovascular Risk Factors and Lifestyles With the Cardio-ankle Vascular Index in a General Mediterranean Population. Rev Esp Cardiol (Engl Ed) 2018;71:458–465. doi: 10.1016/j.recesp.2017.09.004. PubMed DOI

Laucevicius A, Ryliskyte L, Balsyte J, Badariene J, Puronaite R, Navickas R, Solovjova S. Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients. Med (Kaunas) 2015;51:152–158. PubMed

Wakabayashi I, Masuda H. Relationships between vascular indexes and atherosclerotic risk factors in patients with type 2 diabetes mellitus. Angiology. 2008;59:567–573. doi: 10.1177/0003319707312517. PubMed DOI

Topouchian J, Labat C, Gautier S, Back M, Achimastos A, Blacher J, Cwynar M, de la Sierra A, Pall D, Fantin F, et al. Effects of metabolic syndrome on arterial function in different age groups: the advanced approach to arterial stiffness study. J Hypertens. 2018;36:824–833. doi: 10.1097/HJH.0000000000001631. PubMed DOI PMC

Wang H, Liu J, Zhao H, Fu X, Shang G, Zhou Y, Yu X, Zhao X, Wang G, Shi H. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects. J Am Soc Hypertens. 2013;7:426–431. doi: 10.1016/j.jash.2013.06.003. PubMed DOI

Zhao X, Bo L, Zhao H, Li L, Zhou Y, Wang H. Cardio-ankle vascular index value in dyslipidemia patients affected by cardiovascular risk factors. Clin Exp Hypertens. 2018;40:312–317. doi: 10.1080/10641963.2017.1377213. PubMed DOI

Wang H, Liu J, Zhao H, Zhao X, Li L, Shi H, Zhan S, Liu J. Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects. J Hum Hypertens. 2015;29:105–108. doi: 10.1038/jhh.2014.37. PubMed DOI

Nagayama D, Watanabe Y, Saiki A, Shirai K, Tatsuno I. Lipid parameters are independently associated with cardio-ankle vascular index (CAVI) in healthy Japanese subjects. J Atheroscler Thromb. 2018;25:621–633. doi: 10.5551/jat.42291. PubMed DOI PMC

Wang X, Ye P, Cao R, Yang X, Xiao W, Zhang Y, Bai Y, Wu H. Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2016;15:97. doi: 10.1186/s12944-016-0266-8. PubMed DOI PMC

Hirasada K, Niimura H, Kubozono T, Nakamura A, Tatebo M, Ogawa S, Tsunematsu N, Chiba S, Matsushita T, Kusano K, et al. Values of cardio-ankle vascular index (CAVI) between Amami islands and Kagoshima mainland among health checkup examinees. J Atheroscler Thromb. 2012;19:69–80. doi: 10.5551/jat.6627. PubMed DOI

Movsisyan NK, Vinciguerra M, Lopez-Jimenez F, Kunzova S, Homolka M, Jaresova J, Cifkova R, Sochor O. Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: methods, baseline findings and future directions. Eur J Prev Cardiol. 2018;25:54–64. doi: 10.1177/2047487317726623. PubMed DOI

Czech Health Statistics Yearbook 2013 [https://www.uzis.cz/en/publications/czech-health-statistics-yearbook-2013].

Cholesterol test [https://www.mayoclinic.org/tests-procedures/cholesterol-test/about/pac-20384601].

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–188. doi: 10.1093/eurheartj/ehz455. PubMed DOI

Kabutoya T, Kario K. Comparative assessment of cutoffs for the cardio-ankle vascular index and brachial-ankle pulse wave velocity in a Nationwide registry: a cardiovascular prognostic coupling study. Pulse (Basel) 2019;6:131–136. doi: 10.1159/000489604. PubMed DOI PMC

Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Frontera G, Ramos R, Marti R, Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez JA, et al. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in Caucasian adults: MARK study. J Atheroscler Thromb. 2015;22:901–911. doi: 10.5551/jat.28035. PubMed DOI

Hu H, Cui H, Han W, Ye L, Qiu W, Yang H, Zhang C, Guo X, Mao G. A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis. Hypertens Res. 2013;36:334–341. doi: 10.1038/hr.2012.192. PubMed DOI

Tanaka A, Tomiyama H, Maruhashi T, Matsuzawa Y, Miyoshi T, Kabutoya T, Kario K, Sugiyama S, Munakata M, Ito H, et al. Physiological Diagnostic Criteria for Vascular Failure. Hypertension. 2018;72:1060–1071. PubMed

Miyoshi T, Ito H. Assessment of arterial stiffness using the cardio-ankle vascular index. Pulse (Basel) 2016;4:11–23. PubMed PMC

Reiner Z, Simental-Mendia LE, Ruscica M, Katsiki N, Banach M, Al Rasadi K, Jamialahmadi T, Sahebkar A. Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis. Arch Med Sci. 2019;15:1365–1374. doi: 10.5114/aoms.2019.89450. PubMed DOI PMC

Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrieres J, Filardi PP, Hancu N, et al. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. Eur Heart J Suppl. 2016;18:C2–C12. doi: 10.1093/eurheartj/suw009. PubMed DOI

Reiner Z. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14:401–411. doi: 10.1038/nrcardio.2017.31. PubMed DOI

Lopes-Vicente WRP, Rodrigues S, Cepeda FX, Jordao CP, Costa-Hong V, Dutra-Marques ACB, Carvalho JC, Alves M, Bortolotto LA, Trombetta IC. Arterial stiffness and its association with clustering of metabolic syndrome risk factors. Diabetol Metab Syndr. 2017;9:87. doi: 10.1186/s13098-017-0286-1. PubMed DOI PMC

Pitha J, Kovar J, Blahova T. Fasting and nonfasting triglycerides in cardiovascular and other diseases. Physiol Res. 2015;64:S323–S330. doi: 10.33549/physiolres.933196. PubMed DOI

Sahebkar A, Pecin I, Tedeschi-Reiner E, Derosa G, Maffioli P, Reiner Z. Effects of statin therapy on augmentation index as a measure of arterial stiffness: a systematic review and meta-analysis. Int J Cardiol. 2016;212:160–168. doi: 10.1016/j.ijcard.2016.03.010. PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...